title: Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
authors.affiliation: Department of Pharmacology, I.R.C.C.S. S. Matteo Hospital, Pavia, Italy.
authors.forename: M B
authors.initials: MB
authors.lastname: Regazzi
authors.forename: I
authors.initials: I
authors.lastname: Iacona
authors.forename: C
authors.initials: C
authors.lastname: Campana
authors.forename: A
authors.initials: A
authors.lastname: Gavazzi
authors.forename: M
authors.initials: M
authors.lastname: Viganò
authors.forename: G
authors.initials: G
authors.lastname: Perani
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017035:Pravastatin / Q000097:blood / Q000493:pharmacokinetics*; D019821:Simvastatin; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D017035:Pravastatin